Crystalloids and colloids in critical patient resuscitation;Cristaloides y coloides en la reanimación del paciente crítico

Medicina Intensiva

Volumn 39, Issue 5, 2015, Pages 303-315

  Garnacho Montero, J ^a   Fernandez Mondejar E ^b   Ferrer Roca, R ^c,d   Herrera Gutierrez M E ^e   Lorente, J A ^d,f,g   Ruiz Santana, S ^h   Artigas, A ^d,i  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^g UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^h HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Colloids; Crystalloids; Fluids

Indexed keywords

CHLORINE; HETASTARCH; INFUSION FLUID; SODIUM; COLLOID; CRYSTALLOID; DEXTRAN; GELATIN; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; RINGER'S LACTATE; SERUM ALBUMIN; SODIUM CHLORIDE;

CLINICAL TRIAL (TOPIC); COLLOID; CONCENTRATION (PARAMETERS); CRITICALLY ILL PATIENT; CRYSTALLOID; DEATH; FLUID RESUSCITATION; HUMAN; KIDNEY FAILURE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PATIENT SAFETY; RENAL REPLACEMENT THERAPY; RESUSCITATION; RISK BENEFIT ANALYSIS; SHOCK; SHORT SURVEY; SURVIVAL RATE; ACIDOSIS; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; CHEMICALLY INDUCED; CONSENSUS DEVELOPMENT; CONTRAINDICATIONS; DRUG HYPERSENSITIVITY; FLUID THERAPY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROCEDURES; THERAPEUTIC USE;

ACIDOSIS; ACUTE KIDNEY INJURY; CLINICAL TRIALS AS TOPIC; COLLOIDS; DEXTRANS; DRUG HYPERSENSITIVITY; FLUID THERAPY; GELATIN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; META-ANALYSIS AS TOPIC; OBSERVATIONAL STUDIES AS TOPIC; RENAL REPLACEMENT THERAPY; RESUSCITATION; SALINE SOLUTION, HYPERTONIC; SERUM ALBUMIN; SHOCK;

EID: 84930379606     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2014.12.007     Document Type: Short Survey

References (87)

1. Myburgh J.A., Mythen M.G. Resuscitation fluids. N Engl J Med. 2013, 369:1243-1251.
2. Finfer S., Liu B., Taylor C., Bellomo R., Billot L., Cook D., et al. Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care. 2010, 14:R185. SAFE TRIPS Investigators.
3. Reinhart K., Perner A., Sprung C.L., Jaeschke R., Schortgen F., Johan Groeneveld A.B., et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012, 38:368-383.
4. Woodcock T.E., Woodcock T.M. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: An improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012, 108:384-394.
5. Jacob M., Chappell D., Hofmann-Kiefer K., Helfen T., Schuelke A., Jacob B., et al. The intravascular volume effect of Ringer's lactate is below 20%: A prospective study in humans. Crit Care. 2012, 16:R86.
6. Agencia Española de Medicamentos y Productos Sanitarios [consultado 12 Sep 2014]. Disponible en: . http://www.aemps.gob.es/.
7. Gondos T., Marjanek Z., Ulakcsai Z., Szabó Z., Bogár L., Károlyi M., et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol. 2010, 27:794-800.
8. Basora M., Vidal V., Llau J.V., Silva S. Utilización perioperatoria de coloides por los anestesiólogos españoles: encuesta de opinión. Rev Esp Anestesiol Reanim. 2007, 54:162-168.
9. Webb A.R., Barclay S.A., Bennett E.D. In vitro colloid osmotic pressure of commonly used plasma expanders and substitutes: A study of the diffusibility of colloid molecules. Intensive Care Med. 1989, 15:116-120.
10. Apostolou E., Deckert K., Puy R., Sandrini A., de Leon M.P., Douglass J.A., et al. Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: A case series. Anaesthesia. 2006, 61:264-268.
11. Lobo D.N., Stanga Z., Aloysius M.M., Wicks C., Nunes Q.M., Ingram K.L., et al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover study in healthy volunteers. Crit Care Med. 2010, 38:464-470.
12. Davidson I.J. Renal impact of fluid management with colloids: A comparative review. Eur J Anaesthesiol 2006, 23:721-738.
13. Bellmann R., Feistritzer C., Wiedermann C.J. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: A meta-analysis of clinical studies. Clin Pharmacokinet. 2012, 51:225-236.
14. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ 1998, 317:235-240. Cochrane Injuries Group Albumin Reviewers.
15. Vincent J.L. Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 2009, 23:183-191.
16. Ulldemolins M., Roberts J.A., Rello J., Paterson D.L., Lipman J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 2011, 50:99-110.
17. Finfer S., Bellomo R., McEvoy S., Lo S.K., Myburgh J., Neal B., et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: Analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006, 333:1044. SAFE Study Investigators.
18. Vincent J.L., Dubois M.J., Navickis R.J., Wilkes M.M. Hypoalbuminemia in acute illness: Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003, 237:319-334.
19. Schortgen F., Deye N., Brochard L. Preferred plasma volume expanders for critically ill patients: Results of an international survey. Intensive Care Med 2004, 30:2222-2229. CRYCO Study Group.
20. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256. SAFE Study Investigators.
21. Myburgh J.A., Finfer S., Bellomo R., Billot L., Cass A., Gattas D., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012, 367:1901-1911. CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.
22. Yunos N.M., Bellomo R., Hegarty C., Story D., Ho L., Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012, 308:1566-1572.
23. Prough D.S., Bidani A. Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 1999, 90:1247-1249.
24. Scheingraber S., Rehm M., Sehmisch C., Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999, 90:1265-1270.
25. O'Malley C.M., Frumento R.J., Hardy M.A., Benvenisty A.I., Brentjens T.E., Mercer J.S., et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg. 2005, 100:1518-1524.
26. Todd S.R., Malinoski D., Muller P.J., Schreiber M.A. Lactated Ringer's is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma 2007, 62:636-639.
27. Waters J.H., Gottlieb A., Schoenwald P., Popovich M.J., Sprung J., Nelson D.R. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: An outcome study. Anesth Analg. 2001, 93:817-822.
28. O'Dell E., Tibby S.M., Durward A., Murdoch I.A. Hyperchloremia is the dominant cause of metabolic acidosis in the postresuscitation phase of pediatric meningococcal sepsis. Crit Care Med 2007, 35:2390-2394.
29. Noritomi D.T., Soriano F.G., Kellum J.A., Cappi S.B., Biselli P.J., Libório A.B., et al. Metabolic acidosis in patients with severe sepsis and septic shock: A longitudinal quantitative study. Crit Care Med 2009, 37:2733-2739.
30. ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012, 256:18-24.
31. Kellum J.A. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: Improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 2002, 30:300-305.
32. Scheingraber S., Rehm M., Sehmisch C., Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999, 90:1265-1270.
33. Wilkes N.J., Woolf R., Mutch M., Mallett S.V., Peachey T., Stephens R., et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001, 93:811-816.
34. Takil A., Eti Z., Irmak P., Yilmaz Göğüş F. Early postoperative respiratory acidosis after large intravascular volume infusion of lactated ringer's solution during major spine surgery. Anesth Analg. 2002, 95:294-298.
35. Bruegger D., Jacob M., Scheingraber S., Conzen P., Becker B.F., Finsterer U., et al. Changes in acid-base balance following bolus infusion of 20% albumin solution in humans. Intensive Care Med. 2005, 31:1123-1127.
36. Raghunathan K., Shaw A., Nathanson B., Stürmer T., Brookhart A., Stefan M.S., et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014, 42:1585-1591.
37. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., Goyal M., Fuchs B.D., Shah C.V., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009, 37:1670-1677.
38. Didwania A., Miller J., Kassel D., Jackson E.V., Chernow B. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med 1997, 25:1851-1854.
39. Shin W.J., Kim Y.K., Bang J.Y., Cho S.K., Han S.M., Hwang G.S. Lactate and liver function tests after living donor right hepatectomy: A comparison of solutions with and without lactate. Acta Anaesthesiol Scand. 2011, 55:558-664.
40. Diringer M.N. New trends in hyperosmolar therapy?. Curr Opin Crit Care. 2013, 19:77-82.
41. Yunos N.M., Kim I.B., Bellomo R., Bailey M., Ho L., Story D., et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2014, 201:2419-2424.
42. Shaw A.D., Bagshaw S.M., Goldstein S.L., Scherer L.A., Duan M., Schermer C.R., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012, 255:821-829.
43. Hasman H., Cinar O., Uzun A., Cevik E., Jay L., Comert B. A randomized clinical trial comparing the effect of rapidly infused crystalloids on acid-base status in dehydrated patients in the emergency department. Int J Med Sci 2012, 9:59-64.
44. Young J.B., Utter G.H., Schermer C.R., Galante J.M., Phan H.H., Yang Y., et al. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: A randomized trial. Ann Surg. 2014, 259:255-262.
45. Roquilly A., Loutrel O., Cinotti R., Rosenczweig E., Flet L., Mahe P.J., et al. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: A randomised double-blind pilot study. Crit Care. 2013, 17:R77.
46. Lehmann L., Bendel S., Uehlinger D.E., Takala J., Schafer M., Reinert M., et al. Randomized, double-blind trial of the effect of fluid composition on electrolyte, acid-base, and fluid homeostasis in patients early after subarachnoid hemorrhage. Neurocrit Care. 2013, 18:5-12.
47. Burdett E., Dushianthan A., Bennett-Guerrero E., Cro S., Gan T.J., Grocott M.P., et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev. 2012, 12:CD004089.
48. Rochwerg B., Alhazzani W., Sindi A., Heels-Ansdell D., Thabane L., Fox-Robichaud A., et al. Fluid resuscitation in sepsis: A systematic review and network meta-analysis. Ann Intern Med. 2014, 161:347-355.
49. Guidet B., Martinet O., Boulain T., Philippart F., Poussel J.F., Maizel J., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012, 16:R94.
50. James M.F., Michell W.L., Joubert I.A., Nicol A.J., Navsaria P.H., Gillespie R.S. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011, 107:693-702.
51. Wiedermann C.J., Joannidis M. Accumulation of hydroxyethyl starch in human and animal tissues: A systematic review. Intensive Care Med. 2014, 40:160-170.
52. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
53. McIntyre L.A., Fergusson D., Cook D.J., Nair R.C., Bell D., Dhingra V., et al. Resuscitating patients with early severe sepsis: A Canadian multicentre observational study. Can J Anaesth. 2007, 54:790-798. Canadian Critical Care Trials Group.
54. Perner A., Haase N., Guttormsen A.B., Tenhunen J., Klemenzson G., Åneman A., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134. 6S Trial Group; Scandinavian Critical Care Trials Group.
55. Sakr Y., Payen D., Reinhart K., Sipmann F.S., Zavala E., Bewley J., et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007, 98:216-224.
56. Hartog C.S., Skupin H., Natanson C., Sun J., Reinhart K. Systematic analysis of hydroxyethyl starch (HES) reviews: Proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Med 2012, 38:1258-1271.
57. Wiedermann C.J., Joannidis M. Mortality after hydroxyethyl starch 130/0.4 infusion: An updated meta-analysis of randomized trials. Swiss Med Wkly. 2012, 142:w13656.
58. Gattas D.J., Dan A., Myburgh J., Billot L., Lo S., Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: An updated systematic review and meta-analysis. Anesth Analg. 2012, 114:159-169. CHEST Management Committee.
59. Zarychanski R., Abou-Setta A.M., Turgeon A.F., Houston B.L., McIntyre L., Marshall J.C., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA. 2013, 309:678-688.
60. Gattas D.J., Dan A., Myburgh J., Billot L., Lo S., Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013, 39:558-568. CHEST Management Committee.
61. Haase N., Perner A., Hennings L.I., Siegemund M., Lauridsen B., Wetterslev M., et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis. BMJ. 2013, 346:f839.
62. Martin C., Jacob M., Vicaut E., Guidet B., van Aken H., Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013, 118:387-394.
63. Zhong J.Z., Wei D., Pan H.F., Chen Y.J., Liang X.A., Yang Z.Y., et al. Colloid solutions for fluid resuscitation in patients with sepsis: Systematic review of randomized controlled trials. J Emerg Med. 2013, 45:485-495.
64. Agencia Española de Medicamentos y Productos Sanitarios. Soluciones intravenosas de hidroxietil-almidón: restricciones de uso [consultado 12 Sep 2014]. Disponible en: . http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/docs/NI-MUH_FV_29-hidroxietil-almidon.pdf.
65. Annane D., Siami S., Jaber S., Martin C., Elatrous S., Declère A.D., et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA 2013, 310:1809-1817. CRISTAL Investigators.
66. Thomas-Rueddel D.O., Vlasakov V., Reinhart K., Jaeschke R., Rueddel H., Hutagalung R., et al. Safety of gelatin for volume resuscitation--A systematic review and meta-analysis. Intensive Care Med. 2012, 38:1134-1142.
67. Parker M.J., Griffiths R., Boyle A. Preoperative saline versus gelatin for hip fracture patients; a randomized trial of 396 patients. Br J Anaesth. 2004, 92:67-70.
68. Schortgen F., Lacherade J.C., Bruneel F., Cattaneo I., Hemery F., Lemaire F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet. 2001, 357:911-916.
69. Cittanova M.L., Leblanc I., Legendre C., Mouquet C., Riou B., Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996, 348:1620-1622.
70. Mahmood A., Gosling P., Vohra R.K. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007, 94:427-433.
71. Bayer O., Reinhart K., Kohl M., Kabisch B., Marshall J., Sakr Y., et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis. Crit Care Med. 2012, 40:2543-2551.
72. Bayer O., Schwarzkopf D., Doenst T., Cook D., Kabisch B., Schelenz C., et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--A prospective sequential analysis. Crit Care Med 2013, 41:2532-2542.
73. Schortgen F., Girou E., Deye N., Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med. 2008, 34:2157-2168. CRYCO Study Group.
74. Van der Heijden M., Verheij J., van Nieuw Amerongen G.P., Groeneveld A.B. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med. 2009, 37:1275-1281.
75. Schabinski F., Oishi J., Tuche F., Luy A., Sakr Y., Bredle D., et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009, 35:1539-1547.
76. Saw M.M., Chandler B., Ho K.M. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: A meta-analysis. Anaesth Intensive Care 2012, 40:17-32.
77. Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37:86-96.
78. Delaney A.P., Dan A., McCaffrey J., Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis. Crit Care Med 2011, 39:386-391.
79. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
80. Caironi P., Tognoni G., Masson S., Fumagalli R., Pesenti A., Romero M., et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014, 10:1412-1421.
81. Myburgh J., Cooper D.J., Finfer S., Bellomo R., Norton R., Bishop N., et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357:874-884.
82. Cooper D.J., Myburgh J., Heritier S., Finfer S., Bellomo R., Billot L., et al. Albumin resuscitation for traumatic brain injury: Is intracranial hypertension the cause of increased mortality?. J Neurotrauma 2013, 30:512-518.
83. Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
84. Kwok C.S., Krupa L., Mahtani A., Kaye D., Rushbrook S.M., Phillips M.G., et al. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: A systematic review and meta-analysis. Biomed Res Int 2013, 2013:295153.
85. Bernardi M., Caraceni P., Navickis R.J., Wilkes M.M. Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials. Hepatology. 2012, 55:1172-1181.
86. Estébanez-Montiel M.B., Quintana-Díaz M., García de Lorenzo y Mateos A., Blancas Gomez-Casero R., Acosta-Escribano J., Marcos-Neira P. Resultados de una encuesta sobre la práctica clínica habitual en el empleo de albúmina en UCI. Med Intensiva. 2014, 38:403-412. grupos de Trabajo de Transfusiones y Hemoderivados, y de Metabolismo y Nutrición de la Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC).
87. Latour-Pérez J. Nuevas recomendaciones sobre la utilización de soluciones de albúmina humana en pacientes con sepsis grave y shock séptico. Una evaluación crítica de la literatura. Med Intensiva 2013, 37:409-415.